St. Anna Children's Cancer Research Institute (CCRI)
Michael Kraakman is currently a Postdoctoral Researcher at the St. Anna Children's Cancer Research Institute (CCRI) since April 2019. Prior to this role, Michael Kraakman served as a Postdoctoral Research Fellow at Columbia University Vagelos College of Physicians and Surgeons from July 2015 to March 2019, and completed a PhD in Biochemistry and Molecular Biology at the Baker Heart and Diabetes Institute between January 2010 and March 2015. Educational qualifications include a Doctor of Philosophy from Monash University (2010-2015), a Graduate Diploma in Science from Massey University (2009-2010), and a Bachelor of Physical Education in Exercise Physiology and Metabolism from the University of Otago (2005-2008).
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).